Topiramate Tablet
Product Images NDC 76420-276

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 76420-276). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)
Chemical structure of Topiramate, showing its molecular arrangement with multiple rings, oxygen atoms, and functional groups including sulfonamide and methyl groups, as depicted in the image.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)
Kaplan-Meier curve chart showing cumulative rates for time to first seizure over days for Topiramate 50 mg/day versus 400 mg/day dosages. The x-axis represents time in days up to 500, and the y-axis shows cumulative seizure rates. The chart compares seizure occurrence between two dose groups with statistical significance (p = 0.0002).*
FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)
A bar graph displaying the change from baseline to double-blind phase in average weekly migraine days for placebo and Topamax (topiramate) at 50 mg/day, 100 mg/day, and 200 mg/day dosages. Two studies are represented, with data showing greater reductions in migraine days for higher Topamax doses compared to placebo. Statistical significance is noted with asterisks for certain dose groups.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 04)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 04)
Four pharmaceutical labels for Topiramate Tablets USP 25 mg from Enovachem Pharmaceuticals, with packaging addresses in Torrance, CA. Each label includes quantity information (30, 60, or 90 tablets), barcodes, NDC numbers (76420-278-30, 76420-278-60, 76420-278-90), and caution statements about prescription use and storage temperature. The tablets are described as white, circular, biconvex, film-coated, and debossed. One label is marked as relabeled for Cipla USA, Inc.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 05)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 05)
Topiramate Tablets USP 50 mg packaging labels from Enovachem Pharmaceuticals, with quantities of 30, 60, and 90 tablets. The labels include NDC numbers 76420-276-30, 76420-276-60, and 76420-276-90, manufactured for Cipla USA, Inc. The tablets are described as light orange, circular, biconvex, film-coated, and debossed. Storage instructions and federal caution are also printed.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 06)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 06)
Labels for Topiramate Tablets, USP 100 mg, an oral tablet product by Enovachem Pharmaceuticals. The image shows multiple labels with National Drug Codes (NDC) 76420-279-30, 76420-279-60, and 76420-279-90, indicating quantities of 30, 60, and 90 tablets respectively. Manufactured for Cipla USA, Inc., the labels include drug status as prescription (RX), packaging information, and storage instructions.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 07)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 07)
Packaging labels for Topiramate Tablets USP 200 mg by Enovachem Pharmaceuticals. Labels include NDCs 76420-280-30, 76420-280-60, and 76420-280-90, with quantities of 30, 60, and 90 tablets respectively. Manufactured for Cipla USA, Inc., the labels show batch and lot numbers as placeholders and include a barcode and QR code. The tablets are described as pink, capsule-shaped, biconvex, film-coated, and debossed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.